Is a complete ETR/4AB research report available?

No complete published report is available for etr/4AB (ETR/4AB) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

etr/4AB stock profile: metrics, valuation and analysis

Market cap	390B
Revenue (ttm)	56.4B
Net income (ttm)	5.5B
EPS (ttm)	€3.10
P/E (trailing)	71.1x
P/E (forward)	16.9x
Dividend	€5.88 (2.62%)
Volume	279
Beta	0.28

All ETR/4AB indicators

Market & fundamental data

Available fields

240

Groups with data

Currency

USD

Showing 240 of 240 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	DE
Employees	57,000
Employees Change	5,000%
Employees Change Percent	10
Enterprise value	EUR 445.4B
Exchange	Deutsche Börse Xetra
Financial currency	USD
First seen	2026-05-10
Industry	Drug Manufacturers - General
Isin	US00287Y1091
Last refreshed	2026-09-05
Market cap	EUR 390B
Price	EUR 222
Price currency	EUR
Rev Per Employee	988,720.45x
Sector	Healthcare
Sector PE	38.49
Sector PE Fwd	14.51
Sic	2836
Symbol	etr/4AB
Website	https://www.abbvie.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	1.41%
EV Earnings	81.15x
EV/EBIT	22.61x
EV/EBITDA	16.61x
EV/FCF	27.94x
EV/Sales	8.04x
FCF yield	4.09%
Forward P/E	16.93x
P/B ratio	-75.67x
P/E ratio	71.06x
P/S ratio	6.92x
PE Ratio10 Y	41.3x
PE Ratio3 Y	81.44x
PE Ratio5 Y	58.76x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	35.56%
EBITDA Margin	47.78%
FCF margin	28.75%
Gross margin	72.79%
Gross Profit	EUR 41B
Gross Profit Growth	12.78%
Gross Profit Growth Q	14.64%
Gross Profit Growth3 Y	5.88%
Gross Profit Growth5 Y	5.07%
Net Income	EUR 5.5B
Net Income Growth	67.69%
Net Income Growth Q	285.18%
Net Income Growth Qo Q	424.16%
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Net Income Growth3 Y	-10.12%
Net Income Growth5 Y	-1.02%
Pretax Margin	13.51%
Profit Margin	9.8%
Profit Per Employee	EUR 96,283
Profitable Quarters	EUR 6
Profitable Years	17
ROA	10.51
Roa5y	8.68
ROCE	24.49
Roe5y	1,295.2
ROIC	17.7
Roic5y	21.99

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	17.86%
Cagr1y	25.42%
Cagr3y	21.36%
Cagr5y	23.27%
Div CAGR3	2.22%
Div CAGR5	6.65%
EPS Growth	68.54
EPS Growth Q	290.4
EPS Growth Qo Q	422.7
EPS Growth Quarters	1
EPS Growth Years	0
EPS Growth3 Y	-10.05
EPS Growth5 Y	-0.92
FCF Growth	-0.16%
FCF Growth Q	-36.24%
FCF Growth Qo Q	-12.63%
FCF Growth3 Y	-9.78%
FCF Growth5 Y	-1.43%
OCF Growth	1.16%
OCF Growth Q	-33.32%
OCF Growth Qo Q	-10.26%
OCF Growth10 Y	9.1%
OCF Growth3 Y	-8.59%
OCF Growth5 Y	-0.94%
Revenue Growth	10.39x
Revenue Growth Q	10.16x
Revenue Growth Qo Q	13.25x
Revenue Growth Quarters	10x
Revenue Growth Years	2x
Revenue Growth3 Y	4.75x
Revenue Growth5 Y	3.69x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.47
Assets	EUR 118.3B
Cash	EUR 5.7B
Current Assets	EUR 29B
Current Liabilities	EUR 35.9B
Debt	EUR 62B
Debt EBITDA	EUR 2.28
Debt FCF	EUR 3.89
Equity	EUR -5.2B
Interest Coverage	7.85
Liabilities	EUR 123.4B
Long Term Assets	EUR 89.3B
Long Term Liabilities	EUR 87.6B
Net Cash	EUR -56.3B
Net Cash By Market Cap	EUR -14.44
Net Debt EBITDA	EUR 2.09
Net Debt FCF	EUR 3.53
Tangible Book Value	EUR -79.3B
Tangible Book Value Per Share	EUR -44.87
WACC	5.41

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.81
Inventory Turnover	3.47
Net Working Capital	EUR -5.4B
Quick ratio	0.49
Working Capital	EUR -7B
Working Capital Turnover	EUR -6.1

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.03%
Dividend Growth	0.38%
Dividend Growth Years	6%
Dividend per share	EUR 5.88
Dividend Years	8
Dividend Yield	2.62%
Ex Div Date	2026-07-15
Last Dividend	EUR 1.51
Payout Frequency	Quarterly
Payout Ratio	189.83%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	417.28%
1Y total return	25.41%
200-day SMA	196.7
3Y total return	78.78%
50-day SMA	221.5
50-day SMA vs 200-day SMA	50over200
5Y total return	184.58%
All Time High	234.4
All Time High Change	-5.46%
All Time High Date	2026-07-29
All Time Low	41
All Time Low Change	440.49%
All Time Low Date	2014-10-15
ATR	4.18
Beta	0.28
Ch YTD	12.72
High	225.3
High52	234.4
High52 Date	2026-07-29
High52ch	-5.46%
Low	220.9
Low52	162.9
Low52 Date	2026-04-29
Low52ch	36.08%
Ma50ch	0.02%
Price vs 200-day SMA	12.69%
RSI	50.35
RSI Monthly	66.51
RSI Weekly	58.77
Sharpe ratio	0.82x
Sharpe Ratio3y	0.71x
Sharpe Ratio5y	0.82x
Sortino ratio	1.43
Sortino Ratio3y	1.21
Sortino Ratio5y	1.37
Total Return	2.59%
Tr YTD	15.38
Tr1m	3.5%
Tr1w	0.05%
Tr3m	18.46%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,763,987,514%
Net Borrowing	359,879,608
Shares Insiders	0.07%
Shares Institutions	76.61%
Shares Qo Q	-0.23%
Shares Yo Y	0.03%
Short Ratio	2.85

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 15.1B
Adjusted OCF	16,220,184,300
Average Volume	392.7x
Bv Per Share	-2.94
CAPEX	EUR -1.1B
Ch10y	284.7
Ch1m	3.5
Ch1w	0.05
Ch1y	21.63
Ch3m	17.62
Ch3y	61.16
Ch5y	136.9
Ch6m	10.52
Change	-1.25%
Change From Open	-1.07
Close	224.4
Days Gap	-0.18
Depreciation Amortization	6,774,862,764
Dollar Volume	61,826.4
Earnings Date	2026-10-29
EBIT	EUR 20B
EBITDA	EUR 26.9B
EPS	EUR 3.1
F Score	8
FCF	EUR 15.9B
FCF EV Yield	3.58x
Financing CF	-11,283,492,300
Fiscal Year End	December
Founded	2,012
Goodwill	30,580,296,164
Income Tax	EUR 2.1B
Investing CF	-5,687,699,400
Is Primary Listing	0
Last Earnings Date	2026-07-31
Last Report Date	2026-06-30
Lynch Fair Value	EUR 15.59
Lynch Upside	-92.96
Ma150	198.2
Ma150ch	11.81%
Ma20	221.7
Ma20ch	-0.03%
Net CF	89,280,600
Next Earnings Date	2026-10-29
Open	224
P FCF Ratio	24.47
P FCF Ratio SBC	25.85
P OCF Ratio	22.84
P OCF Ratio SBC	24.04
Payment Date	2026-08-14
Position In Range	15.91
Ppne	4,990,100,976
Price Date	2026-09-04
Price EBITDA	EUR 14.48
Relative Volume	0.7x
Revenue	56,357,065,800x
SBC By Revenue	1.52x
Share Based Comp	854,292,800
Tax By Revenue	3.7x
Tax Rate	27.39%
Tr6m	12.24%
Volume	279
Z Score	2.42

ETR/4AB (ETR/4AB)

Price

Financial snapshot

Fair-value bridge

Latest news · ETR/4AB

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ETR/4AB indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on ETR/4AB

Frequently asked questions